These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16835472)

  • 1. [Current status and problems of anticancer drug-induced lung injuries].
    Kudoh S; Yoshimura A
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):881-6. PubMed ID: 16835472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial lung disease and gefitinib.
    Murashige N; Tanimoto T; Oshima Y
    N Engl J Med; 2010 Oct; 363(16):1578-9; author reply 1579-80. PubMed ID: 20942679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-induced lung injury].
    Iwanaga K; Tohda Y
    Arerugi; 2007 Jan; 56(1):37-40. PubMed ID: 17272956
    [No Abstract]   [Full Text] [Related]  

  • 4. Gefitinib-induced interstitial lung disease showing improvement after cessation: disassociation of serum markers.
    Kitajima H; Takahashi H; Harada K; Kanai A; Inomata S; Taniguchi H; Saikai T; Abe S
    Respirology; 2006 Mar; 11(2):217-20. PubMed ID: 16548909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of gefitinib-related interstitial lung disease: multi-institutional analysis by the West Japan Thoracic Oncology Group.
    Endo M; Johkoh T; Kimura K; Yamamoto N
    Lung Cancer; 2006 May; 52(2):135-40. PubMed ID: 16574271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Major drug-induced lung diseases: adverse effects of newly developed molecular targeted drugs].
    Ishikawa N
    Nihon Naika Gakkai Zasshi; 2007 Jun; 96(6):1129-36. PubMed ID: 17607988
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is drug-epidemiology?].
    Kubota K
    Nihon Naika Gakkai Zasshi; 2007 Jun; 96(6):1083-90. PubMed ID: 17607981
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.
    Ando M; Okamoto I; Yamamoto N; Takeda K; Tamura K; Seto T; Ariyoshi Y; Fukuoka M
    J Clin Oncol; 2006 Jun; 24(16):2549-56. PubMed ID: 16735708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy.
    Aoe K; Hiraki A; Murakami T; Maeda T; Umemori Y; Katayama H; Eda R; Takeyama H
    Anticancer Res; 2005; 25(1B):415-8. PubMed ID: 15816604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and toxicity of gefitinib in patients with lung cancer.
    Teramoto S; Yamamoto H; Ouchi Y
    Lancet; 2003 Jun; 361(9373):1992-3. PubMed ID: 12801775
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced interstitial lung diseases associated with molecular-targeted anticancer agents.
    Gemma A
    J Nippon Med Sch; 2009 Feb; 76(1):4-8. PubMed ID: 19305103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.
    Nagaria NC; Cogswell J; Choe JK; Kasimis B
    J Clin Oncol; 2005 Apr; 23(10):2423-4. PubMed ID: 15800334
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the evidence of the Supreme Court Ruling of gefitinib litigation in Japan scientific?
    Katahira K; Yoshikawa T; Enoki H; Teraoka A; Tsuchiya Y
    Int J Risk Saf Med; 2014; 26(4):227-33. PubMed ID: 25420764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung disease associated with gefitinib.
    Kataoka K; Taniguchi H; Hasegawa Y; Kondoh Y; Kimura T; Nishiyama O; Imaizumi K; Kawabe T; Kume H; Shimokata K
    Respir Med; 2006 Apr; 100(4):698-704. PubMed ID: 16137874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute interstitial pnuemonia and gefitinib.
    Sumpter K; Harper-Wynne C; O'Brien M; Congleton J
    Lung Cancer; 2004 Mar; 43(3):367-8. PubMed ID: 15165098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug induced lung injuries in Japanese population].
    Kudo S
    Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1058-62. PubMed ID: 16846055
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced interstitial lung diseases].
    Bonniaud P; Georges M; Favrolt N; Camus P
    Rev Prat; 2014 Sep; 64(7):951-6. PubMed ID: 25362778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum thioredoxin in patients with gefitinib-induced interstitial lung disease.
    Sakuma K; Nakamura H; Nakamura T; Hoshino Y; Ueda S; Ichikawa M; Tabata C; Fujita S; Masago K; Yodoi J; Mishima M; Mio T
    Intern Med; 2007; 46(23):1905-9. PubMed ID: 18057762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced interstitial lung disease].
    Gemma A
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1668-70. PubMed ID: 18931568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
    Tsubata Y; Hamada A; Sutani A; Isobe T
    J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.